ENGAGE THERAPEUTICS
Engage Therapeutics is a biopharmaceutical company bringing innovative medicines to market. The Company’s lead investigational drug is Staccato® alprazolam, a small, easy-to-use hand-held drug-device combination product that leverages an FDA-approved delivery system with FDA-approved alprazolam for the cessation of active and acute epileptic seizures. Staccato alprazolam in a Phase 2a proof of concept study demonstrated reduction of seizure in a photosensitivity model. The product will proceed into an advanced clinical setting leveraging a 505(b)(2) regulatory pathway.
ENGAGE THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2017-01-01
Address:
Summit, New Jersey, United States
Country:
United States
Website Url:
http://www.engagetherapeutics.com
Total Employee:
1+
Status:
Closed
Total Funding:
23.6 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail YouTube DigiCert SSL RapidSSL Media Temple Combell
Current Advisors List
Current Employees Featured
Founder
Investors List
Granite Point Capital
Granite Point Capital investment in Series A - Engage Therapeutics
Lumira Ventures
Lumira Ventures investment in Series A - Engage Therapeutics
Adage Capital Management
Adage Capital Management investment in Series A - Engage Therapeutics
LifeSci Venture Partners
LifeSci Venture Partners investment in Series A - Engage Therapeutics
TPG Biotech
TPG Biotech investment in Series A - Engage Therapeutics
Official Site Inspections
http://www.engagetherapeutics.com
- Host name: 217.19.237.54.static.hosted.by.combell.com
- IP address: 217.19.237.54
- Location: Brussels Belgium
- Latitude: 50.8336
- Longitude: 4.3337
- Timezone: Europe/Brussels
- Postal: 1060
More informations about "Engage Therapeutics"
Engage Therapeutics - Crunchbase Company Profile & Funding
Engage Therapeutics is a biopharmaceutical company bringing innovative medicines to market. The Company’s lead investigational drug is Staccato® alprazolam, a small, easy-to-use hand …See details»
Engage Therapeutics 2025 Company Profile: Valuation, Investors ...
Engage Therapeutics General Information Description. Developer of a drug-device product designed for the immediate termination of an ongoing epileptic seizure. The company's …See details»
Engage Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Engage Therapeutics, Inc. of Summit, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Engage Therapeutics Overview | SignalHire Company Profile
Engage Therapeutics is a private company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. The position …See details»
Engage Therapeutics - Company Profile - Tracxn
Jan 31, 2025 Engage Therapeutics is a clinical-stage biopharma developing an inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures. The Staccato is a …See details»
Engage Therapeutics - VentureRadar
Engage Therapeutics is a biopharmaceutical company bringing innovative medicines to market. The Company's lead investigational drug is Staccatoâ„¢ alprazolam, a small, easy-to-use hand …See details»
UCB acquires Engage Therapeutics: Staccato [®] Alprazolam - A …
Brussels (Belgium) 05 June 2020 – 7:00 (CEST) - regulated information – inside information – UCB announced today the acquisition of Engage Therapeutics, Inc. (Summit, N.J. (U.S.)), a …See details»
Engage Therapeutics - Products, Competitors, Financials, …
Engage Therapeutics a clinical-stage biopharmaceutical company developing a new rescue therapy for people who experience uncontrolled epileptic seizures. On June 5th, 2020, Engage …See details»
Engage Therapeutics CEO and Key Executive Team | Craft.co
Engage Therapeutics's Chairman is Heath Lukatch. Other executives include Gregory T. Mayes, President, Chief Executive Officer and Founder; Stephen D. Collins, Director and 4 others. …See details»
Engage Therapeutics - Craft
Engage Therapeutics is a company developing therapy that can stop an active epileptic seizure. It offers Staccato Alprazolam, a non-invasive, hand-held inhalable device that delivers …See details»
UCB acquires Engage Therapeutics for $125m
Jun 8, 2020 Belgian biopharmaceutical firm UCB has acquired US-based pharmaceutical company Engage Therapeutics for a cash consideration of $125m. The terms of the deal also include up to $145m in potential milestones …See details»
Engage Therapeutics - Contacts, Employees, Board Members
Organization. Engage Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... President, CEO & Founder Greg Mayes. Engage …See details»
Startup developing an inhaler for seizures is acquired by UCB
Jun 5, 2020 UCB , based in Brussels, on Friday said it has acquired Engage Therapeutics of Summit, N.J., for $125 million upfront, with potential milestone payments of up to $145 million. …See details»
Engage Therapeutics CEO, Founder, Key Executive Team, Board of ...
Engage Therapeutics has 1 board of directors, including Gregory Mayes. Name. Firm. Work History. Other Seats. Gregory Mayes. Gregory T. Mayes, J.D. is an accomplished biopharma …See details»
Engagetherapeutics Cyber Security Rating & Vendor Risk Report ...
Engage Therapeutics is a company developing therapy that can stop an active epileptic seizure. It offers Staccato Alprazolam, a non-invasive, hand-held inhalable device that delivers …See details»
Engage Therapeutics - VentureRadar
Similar Companies: Serina Therapeutics USA Private Serina Therapeutics, Inc. has developed a proprietary drug delivery polymer technology based upon the polymer poly(2-oxazoline), or …See details»
Engage Therapeutics Doses First Patient in Phase 2b Trial
May 3, 2018 About Engage Therapeutics, Inc. ... Peachtree BioResearch Solutions, Inc. is a Clinical Research Organization that specializes in providing clinical development services for …See details»
Engage Therapeutics - Facebook
Mar 17, 2020 Engage Therapeutics. 273 likes. Engage Therapeutics is a pharmaceutical company dedicated exclusively to the epilepsy community. We aSee details»
Engage Therapeutics Announces $23M Series A - vcnewsdaily.com
Engage Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a new rescue therapy for people who experience uncontrolled epileptic seizures, announced today the …See details»
Engage Therapeutics bags $23M to trial epilepsy drug-device combo
Sep 27, 2017 Engage Therapeutics, which is developing an EpiPen-like rescue treatment for epileptic seizures, raised $23 million to bankroll a phase 2b clinical trial of its drug-device …See details»